Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
BMC Cancer
; 19(1): 764, 2019 Aug 02.
Article
in En
| MEDLINE
| ID: mdl-31375085
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Drugs, Chinese Herbal
/
Leukemia, Erythroblastic, Acute
/
MAP Kinase Signaling System
/
Melia azedarach
/
Limonins
/
Antineoplastic Agents, Phytogenic
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Year:
2019
Type:
Article